Where Will Baxter International Inc (BAX) Stock Go Next After It Has Gained 1.60% in a Week?

Overall market sentiment has been down on Baxter International Inc (BAX) stock lately. BAX receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Baxter International Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BAX!

See Full BAX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With BAX Stock Today?

Baxter International Inc (BAX) stock is trading at $42.50 as of 3:07 PM on Wednesday, Mar 27, a rise of $0.96, or 2.31% from the previous closing price of $41.54. The stock has traded between $41.74 and $42.63 so far today. Volume today is low. So far 1,869,728 shares have traded compared to average volume of 3,878,199 shares.

More About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app. Click Here to get the full Stock Report for Baxter International Inc stock.